Unilife Corporation has formed a strategic collaboration with Amgen for injectable drug delivery systems. The collaboration, which includes licensing, investment, development and supply agreement components, is centered upon the use of Unilife’s portfolio of prefilled, customizable wearable injectors for medicines to enhance the patient experience. Unilife has granted Amgen exclusive rights to Unilife’s wearable injectors within select drug classes for use with certain Amgen asset...